NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-224 Cr | ₹-55 Cr | ₹-7.48 Cr | ₹-21 Cr | ₹-2.80 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-224 Cr |
| Mar2025 | ₹-55 Cr |
| Mar2024 | ₹-7.48 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹-2.80 Cr |
How is Deferred Tax Assets / Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-224 Cr | Negative | |
| Mar2025 | ₹-55 Cr | Negative | |
| Mar2024 | ₹-7.48 Cr | Negative | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹-2.80 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹238.4 Cr | -3.5% | 13% | -17% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.6% | -1% | 22.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 1.7% | 10.1% | 49.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | 1.5% | -1.2% | 38.2% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | 0.7% | -3.5% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.3% | 0.1% | -7.8% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -3.5% |
13% |
-17% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses